OpenAI, Anthropic Advance IPO Plans as Healthcare AI Expansion Accelerates
Advertisement
The potential public market debuts come as both companies deepen their investments in healthcare AI.
OpenAI and Anthropic have taken formal steps toward potential initial public offerings (IPOs), a move that could draw increased investor attention to two artificial intelligence companies expanding rapidly across healthcare, clinical workflows, and life sciences.
OpenAI recently confirmed it had confidentially submitted an S-1 registration statement to the U.S. Securities and Exchange Commission (SEC), giving the company flexibility to pursue a public listing in the future. While the company has not announced a timeline, Reuters reported that OpenAI CEO Sam Altman told employees he expects the company to go public within the next year and could target a valuation of up to $1 trillion.
A week earlier, Anthropic disclosed that it had confidentially submitted a draft Form S-1 registration statement to the SEC for a proposed IPO of common stock. The company said the offering remains subject to regulatory review, market conditions, and other factors, with pricing and share volume yet to be determined.
The potential public market debuts come as both companies deepen their investments in healthcare AI.
In January, OpenAI launched ChatGPT for Healthcare, a suite of products aimed at helping healthcare organizations deploy AI while supporting HIPAA compliance requirements. The offering is being rolled out across organizations including AdventHealth, Baylor Scott & White Health, Boston Children’s Hospital, Cedars-Sinai Medical Center, HCA Healthcare, Memorial Sloan Kettering Cancer Center, Stanford Medicine Children’s Health, and UCSF.
The company later introduced ChatGPT for Clinicians, a platform designed to provide healthcare professionals with cited answers from medical sources and support research and documentation workflows. OpenAI said the service is available free of charge to verified U.S. clinicians.
Anthropic has also expanded its healthcare footprint through the launch of Claude for Healthcare and Claude for Life Sciences. The company said the platform can support functions such as prior authorization reviews, claims appeals, patient care coordination, regulatory submissions, and research workflows. The HIPAA-ready offering includes integrations with healthcare data sources, including the Centers for Medicare & Medicaid Coverage Database.
Both companies have also strengthened their positions in life sciences. OpenAI partnered with Novo Nordisk on AI-driven drug discovery initiatives, while Anthropic signed an enterprise AI agreement with Bristol Myers Squibb to deploy Claude across engineering, data science, and research teams.
The IPO activity coincides with renewed momentum in health technology public markets. Companies including Oura, Hinge Health, and Omada Health have either filed for or completed public listings over the past year, signaling continued investor interest in healthcare and digital health innovation.
OpenAI recently closed a funding round valuing the company at $852 billion post-money, while Anthropic’s latest financing valued the company at $965 billion, making it one of the most valuable private AI firms globally.
Stay tuned for more such updates on Digital Health News
